showed that in glioblastoma (GBM), BCKAs are heavily mediated by monocarboxylate transporter 1 (MCT 1) and that BCKAs expressed in large quantities are phagocytized and resynthesized into BCAAs by tumor-related macrophages (TAM)
Ze komen voor bij een aanzienlijk deel van de gebruikers, vooral in de eerste weken of na een dosisverhoging
Potential Benefits: Promotes Longevity: By maintaining the integrity of DNA through telomere elongation, Epithalon can contribute to longer life expectancy
Understanding this timeline and how to manage the transition period safely is essential for anyone discontinuing this medication, whether due to side effects, treatment completion, or other medical reasons
doi: 10.1186/s13601-020-00362-7
Missing doses or taking them at inconsistent times can disrupt this steady state, potentially leading to varied therapeutic effects or a greater incidence of side effects as your body struggles to adjust